ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Atorvastatin antagonizes carboplatin, synergizes with the glycolytic inhibitor pfk-158 and induces lipid laden multilamellar bodies in ovarian cancer
Gynecologic Oncology
◽
10.1016/j.ygyno.2018.03.041
◽
2018
◽
Vol 149
(3)
◽
pp. 632-633
Author(s):
E. Kalogera
◽
D. Roy
◽
J.N. Bakkum-Gamez
◽
B.A. Cliby
◽
S.C. Dowdy
◽
...
Keyword(s):
Ovarian Cancer
◽
Multilamellar Bodies
◽
Glycolytic Inhibitor
Download Full-text
Related Documents
Cited By
References
Atorvastatin antagonizes carboplatin, synergizes with the glycolytic inhibitor PFK158 and induces lipid laden multilamellar bodies in ovarian cancer
Gynecologic Oncology
◽
10.1016/j.ygyno.2018.04.145
◽
2018
◽
Vol 149
◽
pp. 64-65
Author(s):
E. Kalogera
◽
D. Roy
◽
J.N. Bakkum-Gamez
◽
B.A. Cliby
◽
S.C. Dowdy
◽
...
Keyword(s):
Ovarian Cancer
◽
Multilamellar Bodies
◽
Glycolytic Inhibitor
Download Full-text
Abstract 5821: Atorvastatin antagonizes carboplatin, synergizes with the glycolytic inhibitor PFK-158, and induces lipid laden multilamellar bodies in ovarian cancer
10.1158/1538-7445.am2018-5821
◽
2018
◽
Author(s):
Eleftheria Kalogera
◽
Debarshi Roy
◽
Jamie N. Bakkum-Gamez
◽
William A. Cliby
◽
Sean C. Dowdy
◽
...
Keyword(s):
Ovarian Cancer
◽
Multilamellar Bodies
◽
Glycolytic Inhibitor
Download Full-text
PFKFB3 AND PLA2G3 KNOCKDOWN LEADS TO THE GENERATION OF LIPID LADEN GRANULAR OSMIOPHILIC DEPOSITS AND MULTILAMELLAR BODIES IN OVARIAN CANCER
10.26226/morressier.599bdc7cd462b80296ca1729
◽
2017
◽
Author(s):
Viji Shridhar
Keyword(s):
Ovarian Cancer
◽
Multilamellar Bodies
Download Full-text
Impact of extended cycles of chemotherapy on survival outcome in recurrent epithelial ovarian cancer
Gynecologic Oncology
◽
10.1016/j.ygyno.2020.05.644
◽
2020
◽
Vol 159
◽
pp. 346-347
Author(s):
W.Y. Hwang
◽
S.I. Kim
◽
M. Lee
◽
K. Kim
◽
J.H. No
◽
...
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Survival Outcome
Download Full-text
Experimental Drug Shows Activity Against Advanced Ovarian Cancer in Phase II Trial
Ob Gyn News
◽
10.1016/s0029-7437(07)70576-1
◽
2007
◽
Vol 42
(13)
◽
pp. 2
Author(s):
PATRICE WENDLING
Keyword(s):
Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Advanced Ovarian Cancer
◽
Experimental Drug
Download Full-text
Oral Contraceptives May Prevent Ovarian Cancer
Skin & Allergy News
◽
10.1016/s0037-6337(08)70172-4
◽
2008
◽
Vol 39
(3)
◽
pp. 49
Author(s):
BRUCE K. DIXON
Keyword(s):
Ovarian Cancer
◽
Oral Contraceptives
Download Full-text
Treatment patterns by decade of life in elderly women (≥70 years of age) with ovarian cancer
Yearbook of Oncology
◽
10.1016/s1040-1741(08)70325-7
◽
2007
◽
Vol 2007
◽
pp. 76-78
Author(s):
J.T. Thigpen
Keyword(s):
Ovarian Cancer
◽
Elderly Women
◽
Treatment Patterns
Download Full-text
Addition of Epirubicin As a Third Drug to Carboplatin-Paclitaxel in First-Line Treatment of Advanced Ovarian Cancer: A Prospectively Randomized Gynecologic Cancer Intergroup Trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour I'Etude des Cancers Ovariens
Yearbook of Oncology
◽
10.1016/s1040-1741(08)70319-1
◽
2007
◽
Vol 2007
◽
pp. 69-70
Author(s):
J.T. Thigpen
Keyword(s):
Ovarian Cancer
◽
Gynecologic Cancer
◽
Advanced Ovarian Cancer
◽
Study Group
◽
Line Treatment
◽
First Line
◽
Cancer Study
◽
Cancer Study Group
◽
Intergroup Trial
◽
First Line Treatment
Download Full-text
Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 Trial
Yearbook of Oncology
◽
10.1016/s1040-1741(08)70316-6
◽
2007
◽
Vol 2007
◽
pp. 66-67
Author(s):
J.T. Thigpen
Keyword(s):
Ovarian Cancer
◽
International Comparison
◽
Advanced Ovarian Cancer
Download Full-text
Toxicity reduction of adenovirus mediated thymidine kinase gene therapy for ovarian cancer and subsequent combination with topoisomerase inhibitors: Design of a clinical phase I study
Journal of the Society for Gynecologic Investigation
◽
10.1016/s1071-5576(97)86111-4
◽
1998
◽
Vol 5
(1)
◽
pp. 47A-47A
◽
Cited By ~ 1
Author(s):
X TONG
◽
D ENGEHAUSEN
◽
D SHINE
◽
I AGOULNIK
◽
T KIM
◽
...
Keyword(s):
Ovarian Cancer
◽
Gene Therapy
◽
Phase I
◽
Thymidine Kinase
◽
Phase I Study
◽
Thymidine Kinase Gene
◽
Topoisomerase Inhibitors
◽
Kinase Gene
◽
Clinical Phase
◽
Toxicity Reduction
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close